
Ke ʻimi nei kēia alakaʻi piha i ka laha ʻana, nā kumu pilikia, ka ʻike, ka mālama ʻana, a me ka pale ʻana ʻO ka maʻi maʻi ate Kina. Hoʻopili mākou i nā noiʻi a me nā holomua hou loa, e hāʻawi ana i nā ʻike waiwai no nā poʻe a me nā limahana mālama olakino. E aʻo e pili ana i nā hoʻolālā kūpono no ka ʻike mua ʻana a me ka hoʻomaikaʻi ʻana i nā hopena i ka mālama ʻana i kēia pilikia olakino koʻikoʻi.
ʻO ka maʻi maʻi ate Kina, ʻo ia hoʻi hepatocellular carcinoma (HCC), he mea koʻikoʻi ke ola olakino ma Kina. ʻOi aku ka kiʻekiʻe o ka maʻi a me ka make ma mua o nā wahi ʻē aʻe o ka honua. Nui nā kumu i hoʻopili i kēia maʻi kiʻekiʻe, ʻo ia hoʻi ka laha ʻana o ka maʻi hepa B (HBV) a me ka maʻi hepa C (HCV), ka ʻike ʻana i ka aflatoxin mai ka meaʻai i hoʻohaumia ʻia, a me nā mea ola e like me ka inu ʻona a me ka hoʻohana ʻana i ka paka. Hiki ke loaʻa ka ʻikepili epidemiological kikoʻī ma nā puke mai ka Chinese Center for Disease Control and Prevention (CDC).
ʻO ka maʻi maʻi me ka HBV a me ka HCV ke kumu nui o ʻO ka maʻi maʻi ate Kina. ʻO kēia mau maʻi maʻi ke kumu o ka ʻeha o ka ate, e alakaʻi ana i ka cirrhosis a ma hope o ka piʻi ʻana o ka ulu ʻana o ka HCC. He mea koʻikoʻi ka pale ʻana i ka HBV. Hiki ke ʻike ʻia ka ʻike e pili ana i ka HBV a me ka HCV prevalence ma Kina ma o ka pūnaewele World Health Organization (WHO).
ʻO Aflatoxins nā mycotoxins carcinogenic i hana ʻia e kekahi mau haʻani e hoʻohaumia pinepine ai i nā meaʻai e like me ka pīni a me ke kulina. ʻO ka hōʻike ʻana i nā aflatoxins kahi mea pilikia nui no ʻO ka maʻi maʻi ate Kina ma nā ʻāina me ka mālama ʻana i nā meaʻai maikaʻi ʻole. Ua hoʻopili nā haʻawina i ka ʻike aflatoxin i kahi kiʻekiʻe o ka HCC.
ʻO nā kumu ʻē aʻe e pili ana: ka hoʻohana ʻana i ka waiʻona, non-alcoholic fatty liver disease (NAFLD), cirrhosis (scarring of the ate), genetic predisposition, a me ka ʻike ʻana i kekahi mau mea kemika. ʻO ka mālama ʻana i ke ola olakino, me ka ʻai kaulike a me ka pale ʻana i ka inu ʻona nui, hiki ke hōʻemi i ka pilikia.
He mea nui ka ʻike mua ʻana no ka hoʻomaikaʻi ʻana i nā hopena ma ʻO ka maʻi maʻi ate Kina. Manaʻo ʻia ka nānā mau ʻana, ʻoi aku ka nui o nā poʻe me nā kumu pilikia. Loaʻa nā ʻano hana diagnostic i nā hoʻāʻo koko (alpha-fetoprotein - AFP), nā ʻenehana kiʻi (ultrasound, CT scan, MRI), a me ka biopsy ate. ʻOkoʻa nā koho lapaʻau ma muli o ke kaʻina o ka maʻi kanesa a hiki ke komo i ka ʻoki ʻana, ka chemotherapy, radiotherapy, ka hoʻōla ʻia ʻana, a me ka hoʻololi ʻana i ka ate. Hiki ke loaʻa ka ʻike hou aʻe e pili ana i nā protocols lapaʻau ma o nā keʻena oncology kaulana e like me ka National Cancer Institute (NCI).
Kāohi ʻana ʻO ka maʻi maʻi ate Kina pili i ka hoʻoponopono ʻana i nā kumu pilikia. Aia kēia me: HBV a me HCV kaʻi ʻana, hoʻomaikaʻi i nā hana palekana meaʻai e hōʻemi i ka ʻike ʻana i ka aflatoxin, pale i ka inu ʻawaʻawa nui, a me ka mālama ʻana i ke ola olakino. He mea koʻikoʻi ka nānā mau ʻana a me ka nānā ʻana, ʻoi aku ka nui o nā poʻe me nā kumu pilikia. No ka poe i ikeia me ʻO ka maʻi maʻi ate Kina, pono nā hoʻolālā hoʻokele piha e pili ana i kahi hui multidisciplinary e hoʻomaikaʻi i ka maikaʻi o ke ola a hoʻolōʻihi i ke ola.
No ka ʻike kikoʻī hou aku ma ʻO ka maʻi maʻi ate Kina, hiki iā ʻoe ke nīnau i kēia mau kumuwaiwai:
Hōʻole: Ua manaʻo ʻia kēia ʻike no nā kumu hoʻonaʻauao wale nō a ʻaʻole pono e manaʻo ʻia he ʻōlelo aʻoaʻo olakino. E kūkākūkā mau me kekahi kauka lapaʻau kūpono no nā pilikia olakino a i ʻole ma mua o ka hoʻoholo ʻana e pili ana i kou olakino a lapaʻau paha.